Amy Green, Hopelab Research Head, Recognized for Health Equity Work

Amy Green, Head of Research at Hopelab, has been recognized as a 2026 Fierce 50 Health Equity honoree by Fierce Pharma, Fierce Biotech, and Fierce Healthcare. The award acknowledges individuals and organizations contributing to advancements in medicine and improving patient care by addressing inequities in the health sector.

The Fierce 50 list identifies 50 individuals and organizations driving progress within the medical field. Green's selection highlights her contributions to conducting socially relevant research and applying its findings to practical solutions aimed at reducing health disparities.

Fierce Pharma, Fierce Biotech, and Fierce Healthcare are recognized industry publications, and their selections are considered significant acknowledgments. Green's award is based on her sustained efforts to mitigate health inequities and enhance healthcare accessibility.

Hopelab is a non-profit organization focused on improving the health and well-being of young people through research and applied initiatives.